Log in or Sign up for Free to view tailored content for your specialty!
Neuroendocrinology News
Cardiometabolic comorbidities more likely for adults with acromegaly than without
Cardiometabolic comorbidities, such as hypertension, cardiac arrythmias and diabetes, are more common in adults with acromegaly than those without the condition, according to a systematic review and meta-analysis published in Pituitary.
FDA approves once-weekly human growth hormone for children with GH deficiency
The FDA in June approved a once-weekly human growth hormone analog for children aged 3 years and older with growth hormone deficiency, according to a company press release.
Log in or Sign up for Free to view tailored content for your specialty!
Most adults with acromegaly achieve normal IGF-I levels with long-acting pasireotide
More than half of adults with acromegaly receiving the somatostatin receptor ligand pasireotide achieved normal insulin-like growth factor I levels, according to data from a long-term real-world study.
Genetic aspects of pituitary tumors: A conversation with Márta Korbonits, MD, PhD, DSc
Márta Korbonits, MD, PhD, DSc, FRCP, uncovered a passion for endocrinology from a series of inspirational lectures during her medical training.
VIDEO: Pituitary research presented at ENDO 2023
CHICAGO —In this video exclusive, John Carmichael, MD, discusses some of the pituitary research presented at ENDO 2023, including treatments for Cushing’s syndrome and adipose effects following acromegaly cure.
VIDEO: Chronic hormonal effects to look for following traumatic brain injury
CHICAGO—In this video exclusive, Tamara Wexler, MD, PhD, discusses evaluation and treatment of pituitary hormone deficiencies that can occur after acquired brain injury, from mild to severe concussions.
A coming ‘renaissance in endocrinology’: A conversation with R. Scott Struthers, PhD
R. Scott Struthers, PhD, had a lab job synthesizing peptide hormones as a college freshman. That experience launched a career featuring discovery of novel agents for endocrine diseases, women’s health conditions and cancers.
VIDEO: Pituitary and adrenal research highlights from ECE 23
In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.
Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome
To achieve optimal outcomes in Cushing’s syndrome, both clinicians and patients need to be prepared for the type and duration of symptoms that patients may experience during treatment and recovery.
Most pituitary microadenomas do not change in size over 5 years of follow-up
Most adults with incident pituitary microadenomas have no change in size or a decrease in size during a median follow-up of nearly 5 years, according to findings published in Annals of Internal Medicine.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read